No Data
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
Change of the top-selling drug! Eli Lilly and Co's Mounjaro surpasses Merck & Co's Keytruda to become the world's best-selling drug.
Eli Lilly and Co's Mounjaro has surpassed Merck & Co's cancer treatment drug Keytruda to become the world's best-selling medication.
EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities, Upcoming Webinar Hosted by Xtalks
AbbVie to Present at the Bank of America Securities Healthcare Conference
Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality
Daiwa Securities Adjusts AbbVie Price Target to $237 From $244, Maintains Outperform Rating